Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567264-25-000077
Filing Date
2025-08-07
Accepted
2025-08-07 16:01:47
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q intensity-20250630.htm   iXBRL 10-Q 772732
2 EX-31.1 a10q20250630exhibit311.htm EX-31.1 11043
3 EX-31.2 a10q20250630exhibit312.htm EX-31.2 11023
4 EX-32.1 a10q20250630exhibit321.htm EX-32.1 5436
5 EX-32.2 a10q20250630exhibit322.htm EX-32.2 5418
  Complete submission text file 0001567264-25-000077.txt   4840345

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250630.xsd EX-101.SCH 38424
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT intensity-20250630_cal.xml EX-101.CAL 48816
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT intensity-20250630_def.xml EX-101.DEF 167138
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250630_lab.xml EX-101.LAB 513056
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250630_pre.xml EX-101.PRE 350929
70 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250630_htm.xml XML 551806
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41109 | Film No.: 251193761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)